Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarun Singhal

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 24, 2026
Case Study 11: A 67-Year-Old Man With Behavioral Disturbances and Frequent FallsSyed Kamal, Naomi Kennel, Alice M Li, et al.
Clinical Nuclear Medicine|April 17, 2024
Glial Activity Load on PET Reveals Persistent "Smoldering" Inflammation in MS Despite Disease-Modifying Treatment: 18 F-PBR06 StudyTarun Singhal, Steven Cicero, Eero Rissanen, et al.
Multiple Sclerosis and Related Disorders|August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomesKathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 14, 2023
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccineSarah Conway, Shrishti Saxena, Clare Baecher-Allan, et al.
Npj Aging|June 5, 2026
Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8<sup>+</sup> T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trialPanayota Kolypetri, Patrick da Silva, Ronaldo S Francisco, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MSTanuja Chitnis, Tarun Singhal, Jonathan Zurawski, et al.
Cerebellum (London, England)|December 1, 2022
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotypingAlain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
Cerebellum (London, England)|October 3, 2022
Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-PhenotypingAlain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 24, 2026
Case Study 11: A 67-Year-Old Man With Behavioral Disturbances and Frequent FallsSyed Kamal, Naomi Kennel, Alice M Li, et al.
Clinical Nuclear Medicine|April 17, 2024
Glial Activity Load on PET Reveals Persistent "Smoldering" Inflammation in MS Despite Disease-Modifying Treatment: 18 F-PBR06 StudyTarun Singhal, Steven Cicero, Eero Rissanen, et al.
Multiple Sclerosis and Related Disorders|August 11, 2022
Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomesKathryn B Holroyd, Brian C Healy, Sarah Conway, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 14, 2023
Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccineSarah Conway, Shrishti Saxena, Clare Baecher-Allan, et al.
Npj Aging|June 5, 2026
Nasal administration of Protollin enhances monocyte phagocytosis and decreases CD8<sup>+</sup> T cell cytotoxicity in subjects with early Alzheimer's disease: a Phase 1 clinical trialPanayota Kolypetri, Patrick da Silva, Ronaldo S Francisco, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MSTanuja Chitnis, Tarun Singhal, Jonathan Zurawski, et al.
Cerebellum (London, England)|December 1, 2022
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotypingAlain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
Cerebellum (London, England)|October 3, 2022
Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-PhenotypingAlain Ndayisaba, Ariana T Pitaro, Andrew S Willett, et al.
Pageof 8